Cargando…

The Different Colors of mAbs in Solution

The color of a therapeutic monoclonal antibody solution is a critical quality attribute. Consistency of color is typically assessed at time of release and during stability studies against preset criteria for late stage clinical and commercial products. A therapeutic protein solution’s color may be d...

Descripción completa

Detalles Bibliográficos
Autor principal: Ambrogelly, Alexandre
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161444/
https://www.ncbi.nlm.nih.gov/pubmed/34073775
http://dx.doi.org/10.3390/antib10020021
_version_ 1783700512826195968
author Ambrogelly, Alexandre
author_facet Ambrogelly, Alexandre
author_sort Ambrogelly, Alexandre
collection PubMed
description The color of a therapeutic monoclonal antibody solution is a critical quality attribute. Consistency of color is typically assessed at time of release and during stability studies against preset criteria for late stage clinical and commercial products. A therapeutic protein solution’s color may be determined by visual inspection or by more quantitative methods as per the different geographical area compendia. The nature and intensity of the color of a therapeutic protein solution is typically determined relative to calibrated standards. This review covers the analytical methodologies used for determining the color of a protein solution and presents an overview of protein variants and impurities known to contribute to colored recombinant therapeutic protein solutions.
format Online
Article
Text
id pubmed-8161444
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81614442021-05-29 The Different Colors of mAbs in Solution Ambrogelly, Alexandre Antibodies (Basel) Review The color of a therapeutic monoclonal antibody solution is a critical quality attribute. Consistency of color is typically assessed at time of release and during stability studies against preset criteria for late stage clinical and commercial products. A therapeutic protein solution’s color may be determined by visual inspection or by more quantitative methods as per the different geographical area compendia. The nature and intensity of the color of a therapeutic protein solution is typically determined relative to calibrated standards. This review covers the analytical methodologies used for determining the color of a protein solution and presents an overview of protein variants and impurities known to contribute to colored recombinant therapeutic protein solutions. MDPI 2021-05-24 /pmc/articles/PMC8161444/ /pubmed/34073775 http://dx.doi.org/10.3390/antib10020021 Text en © 2021 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Ambrogelly, Alexandre
The Different Colors of mAbs in Solution
title The Different Colors of mAbs in Solution
title_full The Different Colors of mAbs in Solution
title_fullStr The Different Colors of mAbs in Solution
title_full_unstemmed The Different Colors of mAbs in Solution
title_short The Different Colors of mAbs in Solution
title_sort different colors of mabs in solution
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161444/
https://www.ncbi.nlm.nih.gov/pubmed/34073775
http://dx.doi.org/10.3390/antib10020021
work_keys_str_mv AT ambrogellyalexandre thedifferentcolorsofmabsinsolution
AT ambrogellyalexandre differentcolorsofmabsinsolution